Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
COVID-19 폐렴의 치료: 태반 유래 세포 요법의 사례
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
administration
AEC
amniotic
Anti-inflammatory
Antiviral
ARDS
candidate
Cell
clinical evidence
clinical trial
clinical trials
conditions
COVID-19
COVID-19 disease
COVID-19 pneumonia
COVID19 pneumonia
cytokine
Cytokine storm
Cytopathic effect
death
Efficiency
elicited
epithelial cell
epithelial cells
excessive immune response
fatality
fetal
fetal membranes
form
Lung infection
membranes
MOST
pharmacological agents
Placenta
Pneumonia
reported
respiratory distress
responsible
rising
severe COVID-19 disease
Severe COVID-19 pneumonia
severe SARS
severe SARS-CoV-2
stromal cell
stromal cells
syndrome
the disease
therapy
Treatment
virus
[DOI] 10.1007/s12015-020-10004-x PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s12015-020-10004-x PMC 바로가기 [Article Type] Article